Samsara BioCapital, LLC Buys Principia Biopharma Inc, Rhythm Pharmaceuticals Inc, Aimmune Therapeutics Inc

• New Purchases: RYTM, AIMT, ACRS, RCKT, BLUE, PTLA, AKRO, AMRN, KALA,
• Added Positions: PRNB, PIRS, ALLK, ISEE, KALV, LQDA, MLND,
• Reduced Positions: SWTX, BLU,

For the details of Samsara BioCapital, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/samsara+biocapital%2C+llc/current-portfolio/portfolio

1. Intercept Pharmaceuticals Inc (ICPT) - 403,688 shares, 15.93% of the total portfolio.
2. Principia Biopharma Inc (PRNB) - 401,046 shares, 14.93% of the total portfolio. Shares added by 30.73%
3. SpringWorks Therapeutics Inc (SWTX) - 625,281 shares, 10.58% of the total portfolio. Shares reduced by 4.32%
4. Odonate Therapeutics Inc (ODT) - 522,637 shares, 9.05% of the total portfolio.
5. Allakos Inc (ALLK) - 270,965 shares, 7.56% of the total portfolio. Shares added by 11.74%

Samsara BioCapital, LLC initiated holding in Rhythm Pharmaceuticals Inc. The purchase prices were between $13.16 and $22.96, with an estimated average price of $18.01. The stock is now traded at around $18.51. The impact to a portfolio due to this purchase was 2.64%. The holding were 276,289 shares as of .

Samsara BioCapital, LLC initiated holding in Aimmune Therapeutics Inc. The purchase prices were between $11.48 and $36.56, with an estimated average price of $25.86. The stock is now traded at around $16.34. The impact to a portfolio due to this purchase was 2.1%. The holding were 232,571 shares as of .

Samsara BioCapital, LLC initiated holding in Aclaris Therapeutics Inc. The purchase prices were between $0.75 and $2.18, with an estimated average price of $1.38. The stock is now traded at around $1.29. The impact to a portfolio due to this purchase was 1.7%. The holding were 2,608,117 shares as of .

Samsara BioCapital, LLC initiated holding in Rocket Pharmaceuticals Inc. The purchase prices were between $9.71 and $25.11, with an estimated average price of $19.93. The stock is now traded at around $19.84. The impact to a portfolio due to this purchase was 1.12%. The holding were 128,197 shares as of .

Samsara BioCapital, LLC initiated holding in Portola Pharmaceuticals Inc. The purchase prices were between $5.78 and $24.74, with an estimated average price of $12.7. The stock is now traded at around $17.82. The impact to a portfolio due to this purchase was 0.71%. The holding were 159,772 shares as of .

Samsara BioCapital, LLC initiated holding in bluebird bio Inc. The purchase prices were between $40.39 and $98.04, with an estimated average price of $75.99. The stock is now traded at around $56.66. The impact to a portfolio due to this purchase was 0.71%. The holding were 24,790 shares as of .

Samsara BioCapital, LLC added to a holding in Principia Biopharma Inc by 30.73%. The purchase prices were between $43.5 and $74.09, with an estimated average price of $58.41. The stock is now traded at around $64.11. The impact to a portfolio due to this purchase was 3.51%. The holding were 401,046 shares as of .

Samsara BioCapital, LLC added to a holding in Pieris Pharmaceuticals Inc by 130.08%. The purchase prices were between $1.61 and $4.24, with an estimated average price of $3.17. The stock is now traded at around $2.72. The impact to a portfolio due to this purchase was 1.31%. The holding were 1,620,249 shares as of .

Samsara BioCapital, LLC added to a holding in IVERIC bio Inc by 23.22%. The purchase prices were between $2.83 and $8.58, with an estimated average price of $5.91. The stock is now traded at around $3.69. The impact to a portfolio due to this purchase was 0.35%. The holding were 862,552 shares as of .

Samsara BioCapital, LLC added to a holding in KalVista Pharmaceuticals Inc by 41.92%. The purchase prices were between $5.8 and $18.56, with an estimated average price of $13.66. The stock is now traded at around $10.15. The impact to a portfolio due to this purchase was 0.24%. The holding were 168,174 shares as of .